Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.7M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
18.9M
-
Shares change
-
-6.67M
-
Total reported value, excl. options
-
$8.39M
-
Value change
-
-$3.56M
-
Put/Call ratio
-
0.22
-
Number of buys
-
32
-
Number of sells
-
-62
-
Price
-
$0.44
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q2 2025
105 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q2 2025.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.9M shares
of 44.7M outstanding shares and own 42.34% of the company stock.
Largest 10 shareholders include AMH Equity Ltd (3.51M shares), Harvey Partners, LLC (2.14M shares), VANGUARD GROUP INC (1.85M shares), Granahan Investment Management, LLC (1.5M shares), DIMENSIONAL FUND ADVISORS LP (1.13M shares), BlackRock, Inc. (1.11M shares), ACADIAN ASSET MANAGEMENT LLC (1.04M shares), Meros Investment Management, LP (920K shares), UBS Group AG (792K shares), and RENAISSANCE TECHNOLOGIES LLC (792K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.